AUPH

Aurinia Pharmaceuticals Inc.

Biotechnology · Biotechnology

$260.51 sample

-3.84 (-1.45%) 1D

Market cap

$861.8B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-18

Alerts

8

Price$260.51 +12.11% 3M daily closessample

267.31228.79

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24INSInsider sell: 10% owner
Sep 18SECForm 144 filed
Sep 15SECForm 144 filed
Sep 04INSInsider buy: Director
Aug 28INSInsider sell: General Counsel
Aug 21SEC10-Q filed
Aug 18SEC10-Q filed
Aug 11INSInsider sell: 10% owner

Sign up to see the real AUPH record →

Company facts

SEC EDGAR registration

Name: Aurinia Pharmaceuticals Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -3sample, -100 to +100
Reporting currency: USD

Who is positioning in AUPH

sample

Insiders: 32 insider transactions over 90 days, net selling, $379.0M
Congress: No member trades over 90 days
Institutions · 13F: 38 funds hold $6.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$41.7B +18.0% y/y

Q4 2024Q3 2026

Inventory$25.5B +13.5% y/y

Q4 2024Q3 2026

Accounts receivable$18.5B +6.8% y/y

Q4 2024Q3 2026

Total debt$52.2B +12.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $202.7B +2.7% 3M
Sample peer B: $536.4B +7.0% 3M
Sample peer C: $147.0B +10.8% 3M
Sample peer D: $143.0B -11.5% 3M
Sample peer E: $530.4B -6.0% 3M